These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31113175)

  • 21. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities.
    Chen Z; Zhao G; Chen F; Xia J; Jiang L
    BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up.
    Jin H; Sun J; Zhu K; Liu X; Zhang Q; Shen Q; Gao Y; Yu J
    Onco Targets Ther; 2017; 10():2655-2664. PubMed ID: 28579803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Shi X; Zhao M; Shi B; Chen G; Yao H; Chen J; Wan D; Gu W; He S
    Front Oncol; 2022; 12():916840. PubMed ID: 36016621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Huang CM; Huang MY; Tsai HL; Huang CW; Su WC; Chang TK; Chen YC; Li CC; Wang JY
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
    Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
    Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of immunologic markers from complete blood counts with the response to preoperative chemoradiotherapy and prognosis in locally advanced rectal cancer.
    Jung SW; Park IJ; Oh SH; Yeom SS; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JB; Yu CS; Kim JC
    Oncotarget; 2017 Aug; 8(35):59757-59765. PubMed ID: 28938679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.
    Ward WH; Goel N; Ruth KJ; Esposito AC; Lambreton F; Sigurdson ER; Meyer JE; Farma JM
    J Surg Res; 2018 Dec; 232():275-282. PubMed ID: 30463730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of esophageal squamous cell carcinoma after neoadjuvant triplet chemotherapy.
    Kubo K; Igaue S; Utsunomiya D; Kubo Y; Kanematsu K; Kurita D; Ishiyama K; Oguma J; Goto K; Daiko H
    Gen Thorac Cardiovasc Surg; 2024 Dec; 72(12):802-809. PubMed ID: 38913280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Associations of Preoperative Platelet-to-lymphocyte Ratio and Derived Neutrophil-to-lymphocyte Ratio with thePrognosis of Gastrointestinal Stromal Tumor].
    Yin XN; Tang SM; Yin Y; Shen CY; Zhang B; Chen ZX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):239-243. PubMed ID: 28612534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive clinical model of tumor response after chemoradiation in rectal cancer.
    Santos MD; Silva C; Rocha A; Nogueira C; Castro-Poças F; Araujo A; Matos E; Pereira C; Medeiros R; Lopes C
    Oncotarget; 2017 Aug; 8(35):58133-58151. PubMed ID: 28938543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
    Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy.
    Zhou J; Lin HP; Xu X; Wang XH; Rong L; Zhang Y; Shen L; Xu L; Qin WT; Ye Q; Ma XM; Bai YR
    Front Immunol; 2022; 13():1041126. PubMed ID: 36451825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive significance of cancer related-inflammatory markers in locally advanced rectal cancer.
    Timudom K; Akaraviputh T; Chinswangwatanakul V; Pongpaibul A; Korpraphong P; Petsuksiri J; Ithimakin S; Trakarnsanga A
    World J Gastrointest Surg; 2020 Sep; 12(9):390-396. PubMed ID: 33024513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.
    Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC
    Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery.
    Zhao J; Xu J; Zhang R
    Med Sci Monit; 2017 Oct; 23():4826-4833. PubMed ID: 28988257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer.
    Kim IY; You SH; Kim YW
    BMC Surg; 2014 Nov; 14():94. PubMed ID: 25406793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
    Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
    PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.